当前位置:首页 - 行情中心 - 九典制药(300705) - 财务分析 - 现金流量表

九典制药

(300705)

  

流通市值:45.41亿  总市值:61.59亿
流通股本:3.69亿   总股本:5.00亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金639,668,451.583,093,353,804.532,556,738,110.521,674,686,634.09
  收到的税费返还8,825.82,592,948.562,592,948.562,592,948.56
  收到其他与经营活动有关的现金7,158,874.3699,633,569.3378,084,760.9362,325,697.48
  经营活动现金流入小计646,836,151.743,195,580,322.422,637,415,820.011,739,605,280.13
  购买商品、接受劳务支付的现金98,304,216.81378,811,920.98543,555,009.04359,739,591.74
  支付给职工以及为职工支付的现金119,653,640.17393,915,565.05300,573,601.96208,844,810.54
  支付的各项税费76,676,221.79301,194,488.87227,211,659.54160,612,709.67
  支付其他与经营活动有关的现金274,327,284.31,474,600,781.061,110,306,616.31734,515,304.29
  经营活动现金流出小计568,961,363.072,548,522,755.962,181,646,886.851,463,712,416.24
  经营活动产生的现金流量净额77,874,788.67647,057,566.46455,768,933.16275,892,863.89
二、投资活动产生的现金流量:
  收回投资收到的现金300,000,000644,999,000570,000,000455,000,000
  取得投资收益收到的现金1,872,254.312,723,263.082,567,260.32,114,567.38
  处置固定资产、无形资产和其他长期资产收回的现金净额3,404.2499,060.02418,984.6332,761.41
  投资活动现金流入小计301,875,658.51648,221,323.1572,986,244.9457,447,328.79
  购建固定资产、无形资产和其他长期资产支付的现金55,866,164.57652,888,846.47343,931,639.48146,985,660.41
  投资支付的现金318,000,000620,200,250515,199,000386,999,000
  取得子公司及其他营业单位支付的现金-8,342,612.148,342,612.140
  支付其他与投资活动有关的现金-0-0
  投资活动现金流出小计373,866,164.571,281,431,708.61867,473,251.62533,984,660.41
  投资活动产生的现金流量净额-71,990,506.06-633,210,385.51-294,487,006.72-76,537,331.62
三、筹资活动产生的现金流量:
  吸收投资收到的现金057,144,276.2326,652,629.8325,152,629.83
  其中:子公司吸收少数股东投资收到的现金031,500,0001,500,0000
  取得借款收到的现金46,550,000226,525,680184,075,680139,175,680
  筹资活动现金流入小计46,550,000283,669,956.23210,728,309.83164,328,309.83
  偿还债务支付的现金4,033,30011,623,3004,666,7004,000,000
  分配股利、利润或偿付利息支付的现金2,172,837.51160,922,453.15158,940,313.92156,172,568.39
  支付其他与筹资活动有关的现金153,363106,233,915.88100,047,173.88100,001,068.88
  筹资活动现金流出小计6,359,500.51278,779,669.03263,654,187.8260,173,637.27
  筹资活动产生的现金流量净额40,190,499.494,890,287.2-52,925,877.97-95,845,327.44
四、汇率变动对现金及现金等价物的影响-38,261.67-57,106.08-21,623.22-11,601.37
五、现金及现金等价物净增加额46,036,520.4318,680,362.07108,334,425.25103,498,603.46
  加:期初现金及现金等价物余额452,199,715.46433,519,353.39433,519,353.39433,519,353.39
  期末现金及现金等价物余额498,236,235.89452,199,715.46541,853,778.64537,017,956.85
补充资料:
  净利润-470,035,433.44-291,423,208.95
  资产减值准备-31,754,939.8-3,958,590.08
  固定资产和投资性房地产折旧-108,587,737.52-52,329,915.63
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-108,587,737.52-52,329,915.63
  无形资产摊销-15,552,735.33-4,221,861.51
  长期待摊费用摊销-1,756,049.61-859,710.53
  处置固定资产、无形资产和其他长期资产的损失--50,728.92--
  固定资产报废损失-4,215,327.29-1,028,593.65
  财务费用-15,529,322.57-6,875,975.94
  投资损失-955,602.86--226,199.83
  递延所得税--2,319,058.26-5,614,434.48
  其中:递延所得税资产减少--7,400,618.74-5,868,167.33
    递延所得税负债增加-5,081,560.48--253,732.85
  存货的减少-31,593,033.73--40,014,009.43
  经营性应收项目的减少--27,802,161.08--35,572,019.62
  经营性应付项目的增加-9,433,349.71--14,870,836.21
  其他--12,343,437.22-212,116.01
  现金的期末余额-452,199,715.46-537,017,956.85
  减:现金的期初余额-433,519,353.39-433,519,353.39
  现金及现金等价物的净增加额-18,680,362.07-103,498,603.46
公告日期2026-04-252026-04-252025-10-302025-08-23
审计意见(境内)标准无保留意见
TOP↑